Literature DB >> 12658506

Guidelines for radioiodinated MIBG scintigraphy in children.

Pierre Olivier1, Paula Colarinha, Jure Fettich, Sibylle Fischer, Jörgen Frökier, Francesco Giammarile, Isky Gordon, Klaus Hahn, Levent Kabasakal, Mike Mann, Mercedes Mitjavila, Amy Piepsz, Ute Porn, Rune Sixt, Jeannette van Velzen.   

Abstract

These guidelines on the use of radioiodinated (99m)Tc-MIBG scintigraphy in children, which summarise the views of the Paediatric Committee of the European Association of Nuclear Medicine, provide a framework which may prove helpful to nuclear medicine teams in daily practice. They have been influenced by the conclusions of the "Consensus Guidelines for MIBG Scintigraphy" (Paris, November 6, 1997) of the European Neuroblastoma Group and by those of the Oncological Committee of the French Society of Nuclear Medicine. The guidelines should be taken in the context of "good practice" and any local/national rules which apply to nuclear medicine examinations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12658506     DOI: 10.1007/s00259-003-1138-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  27 in total

1.  Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.

Authors:  F A Khafagi; B Shapiro; M Fischer; J C Sisson; R Hutchinson; W H Beierwaltes
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Nuclear medicine imaging of pheochromocytoma and neuroblastoma.

Authors:  J C Sisson; B L Shulkin
Journal:  Q J Nucl Med       Date:  1999-09

3.  [123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.

Authors:  V Rufini; A Giordano; D Di Giuda; A Petrone; G Deb; L De Sio; A Donfrancesco; L Troncone
Journal:  Q J Nucl Med       Date:  1995-12

4.  A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine.

Authors:  A Piepsz; K Hahn; I Roca; G Ciofetta; G Toth; I Gordon; J Kolinska; J Gwidlet
Journal:  Eur J Nucl Med       Date:  1990

5.  Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.

Authors:  Y Perel; J Conway; M Kletzel; J Goldman; S Weiss; A Feyler; S L Cohn
Journal:  J Pediatr Hematol Oncol       Date:  1999 Jan-Feb       Impact factor: 1.289

6.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

7.  Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.

Authors:  M J Gelfand; A H Elgazzar; V M Kriss; P R Masters; G J Golsch
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

8.  Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.

Authors:  A Jacobs; M Delree; B Desprechins; J Otten; A Ferster; M H Jonckheer; J Mertens; H R Ham; A Piepsz
Journal:  Pediatr Radiol       Date:  1990

9.  Neuroblastoma, its natural history and prognosis: a study of 487 cases.

Authors:  L M Wilson; G J Draper
Journal:  Br Med J       Date:  1974-08-03

10.  Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.

Authors:  V Rufini; G A Fisher; B L Shulkin; J C Sisson; B Shapiro
Journal:  J Nucl Med       Date:  1996-09       Impact factor: 10.057

View more
  19 in total

1.  131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Francesco Giammarile; Cumali Aktolun; Richard P Baum; Angelika Bischof Delaloye; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Giovanna Pepe; Sven N Reske; Maria R Castellani; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12       Impact factor: 9.236

Review 3.  Staging of common paediatric tumours.

Authors:  Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2009-06

4.  Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Egesta Lopci; Massimo Conte; Luca Foppiani; Stefania Sorrentino; Giovanni Morana; Mehrdad Naseri; Angelina Cistaro; Giampiero Villavecchia; Stefano Fanti; Alberto Garaventa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

5.  Semi-quantitative scoring of skeletal metastases by 123I-mIBG scintigraphy in high-risk neuroblastoma.

Authors:  Mark N Gaze
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-03       Impact factor: 9.236

6.  Guidelines on nuclear medicine imaging in neuroblastoma.

Authors:  Zvi Bar-Sever; Lorenzo Biassoni; Barry Shulkin; Grace Kong; Michael S Hofman; Egesta Lopci; Irina Manea; Jacek Koziorowski; Rita Castellani; Ariane Boubaker; Bieke Lambert; Thomas Pfluger; Helen Nadel; Susan Sharp; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10       Impact factor: 9.236

7.  ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Authors:  Henriette Ingrid Melzer; Eva Coppenrath; Irene Schmid; Michael H Albert; Dietrich von Schweinitz; Coral Tudball; Peter Bartenstein; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-27       Impact factor: 9.236

8.  Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology.

Authors:  Albert Flotats; Ignasi Carrió; Denis Agostini; Dominique Le Guludec; Claudio Marcassa; Michael Schäfers; Michael Schaffers; G Aernout Somsen; Mustafa Unlu; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 9.  Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Authors:  K K Matthay; B Shulkin; R Ladenstein; J Michon; F Giammarile; V Lewington; A D J Pearson; S L Cohn
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

10.  The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.

Authors:  Tom Monclair; Garrett M Brodeur; Peter F Ambros; Hervé J Brisse; Giovanni Cecchetto; Keith Holmes; Michio Kaneko; Wendy B London; Katherine K Matthay; Jed G Nuchtern; Dietrich von Schweinitz; Thorsten Simon; Susan L Cohn; Andrew D J Pearson
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.